Recombinant multi-species ARF4 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine ARF4 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene is a member of the human ARF gene family whose members encode small guanine nucleotide-binding proteins that stimulate the ADP-ribosyltransferase activity of cholera toxin and play a role in vesicular trafficking and as activators of phospholipase D. The gene products include 5 ARF proteins and 11 ARF-like proteins and constitute one family of the RAS superfamily. The ARF proteins are categorized as class I, class II and class III; this gene is a class II member. The members of each class share a common gene organization. The ARF4 gene spans approximately 12kb and contains six exons and five introns. This gene is the most divergent member of the human ARFs. Conflicting map positions at 3p14 or 3p21 have been reported for this gene. [provided by RefSeq, Jul 2008]
The Alternative Names of target: ADP-ribosylation factor 4,ARF2,ARF4,Arf4

Target products collectionGo to ARF4 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP8389-Ag-1/ GM-Tg-hg-IP8389-Ag-2 Human ARF4 protein Human
GM-Tg-rg-IP8389-Ag-1/ GM-Tg-rg-IP8389-Ag-2 Rat ARF4 protein Rat
GM-Tg-mg-IP8389-Ag-1/ GM-Tg-mg-IP8389-Ag-2 Mouse ARF4 protein Mouse
GM-Tg-cynog-IP8389-Ag-1/ GM-Tg-cynog-IP8389-Ag-2 Cynomolgus/Rhesus macaque ARF4 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP8389-Ag-1/ GM-Tg-felg-IP8389-Ag-2 Feline ARF4 protein Feline
GM-Tg-cang-IP8389-Ag-1/ GM-Tg-cang-IP8389-Ag-2 Canine ARF4 protein Canine
GM-Tg-bovg-IP8389-Ag-1/ GM-Tg-bovg-IP8389-Ag-2 Bovine ARF4 protein Bovine
GM-Tg-equg-IP8389-Ag-1/ GM-Tg-equg-IP8389-Ag-2 Equine ARF4 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP8389-Ag-1/ GM-Tg-hg-IP8389-Ag-2; GM-Tg-rg-IP8389-Ag-1/ GM-Tg-rg-IP8389-Ag-2;
GM-Tg-mg-IP8389-Ag-1/ GM-Tg-mg-IP8389-Ag-2; GM-Tg-cynog-IP8389-Ag-1/ GM-Tg-cynog-IP8389-Ag-2;
GM-Tg-felg-IP8389-Ag-1/ GM-Tg-felg-IP8389-Ag-2; GM-Tg-cang-IP8389-Ag-1/ GM-Tg-cang-IP8389-Ag-2;
GM-Tg-bovg-IP8389-Ag-1/ GM-Tg-bovg-IP8389-Ag-2; GM-Tg-equg-IP8389-Ag-1/ GM-Tg-equg-IP8389-Ag-2
Products Name ARF4 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name ARF4
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine ARF4 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.